MAP2K1 and Miyoshi myopathy: LPA's interaction with the LPA2 receptor triggers the downstream MEK1/2-ERK1/2 signaling pathway, enhancing mitochondrial oxidative phosphorylation (OXPHOS), reducing proteasome activity, and improving protein folding in the endoplasmic reticulum, which contributes to MM's resistance to PIs.